UnknownPhase 2

Efficacy of Curcumin in Oral Submucous Fibrosis

India200 participantsStarted 2014-01

Plain-language summary

The purpose of the study is to determine whether the formulations of curcumin will effect the clinical signs and symptoms and histopathological features in patients with clinical stage 2 oral submucous fibrosis (OSMF).

Who can participate

Age range14 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 200 clinical stage 2 OSMF patients Exclusion Criteria: * Clinical stage 1 \& 3 OSMF patients, oromucosal disorders with clinical features same as OSMF, patients who are under treatment, clinically diagnosed cases not ready for incisional biopsy, patients suffering from medically compromised conditions.

What they're measuring

Burning sensation and pain

Timeframe: 6 months for each patient

Trial details

NCT IDNCT03511261

SponsorH.K.E.S's S.Nijalingappa Institute of Dental Science and Research

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12

Contact for this trial

Jayashree Mudda, MDS

+919741804012 jayashreemudda@gmail.com

View on ClinicalTrials.gov More Oral Submucous Fibrosis trials